| Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors E Theander, G Henriksson, O Ljungberg, T Mandl, R Manthorpe, ... Annals of the rheumatic diseases 65 (6), 796-803, 2006 | 703 | 2006 |
| EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome R Seror, P Ravaud, X Mariette, H Bootsma, E Theander, A Hansen, ... Annals of the rheumatic diseases 70 (6), 968-972, 2011 | 549* | 2011 |
| EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome R Seror, P Ravaud, X Mariette, H Bootsma, E Theander, A Hansen, ... Annals of the rheumatic diseases 70 (6), 968-972, 2011 | 549* | 2011 |
| EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 450 | 2020 |
| Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient … R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ... Annals of the rheumatic diseases 75 (2), 382-389, 2016 | 316 | 2016 |
| Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements M Ramos-Casals, P Brito-Zerón, R Seror, H Bootsma, SJ Bowman, ... Rheumatology 54 (12), 2230-2238, 2015 | 307 | 2015 |
| Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ... Annals of the rheumatic diseases 74 (5), 859-866, 2015 | 303 | 2015 |
| Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system E Theander, T Mandl Arthritis Care & Research 66 (7), 1102-1107, 2014 | 200 | 2014 |
| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 184 | 2017 |
| Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations P Brito-Zerón, E Theander, C Baldini, R Seror, S Retamozo, L Quartuccio, ... Expert review of clinical immunology 12 (2), 137-156, 2016 | 183 | 2016 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 174 | 2018 |
| Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity T Mandl, J Marsal, P Olsson, B Ohlsson, K Andréasson Arthritis research & therapy 19, 1-7, 2017 | 133 | 2017 |
| Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden A Mohammad, T Mandl, G Sturfelt, M Segelmark Rheumatology 52 (2), 304-310, 2013 | 120 | 2013 |
| CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome. T Mandl, A Bredberg, LTH Jacobsson, R Manthorpe, G Henriksson The Journal of rheumatology 31 (4), 726-728, 2004 | 88 | 2004 |
| Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjögren’s syndrome? L Theander, B Strömbeck, T Mandl, E Theander Rheumatology 49 (6), 1177-1183, 2010 | 83 | 2010 |
| Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome T Mandl, O Ekberg, P Wollmer, R Manthorpe, LTH Jacobsson Scandinavian journal of rheumatology 36 (5), 394-401, 2007 | 77 | 2007 |
| Epidemiological profile and north–south gradient driving baseline systemic involvement of primary Sjögren’s syndrome P Brito-Zerón, N Acar-Denizli, WF Ng, IF Horvath, A Rasmussen, R Seror, ... Rheumatology 59 (9), 2350-2359, 2020 | 71 | 2020 |
| Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome P Brito-Zerón, S Retamozo, B Kostov, C Baldini, H Bootsma, S De Vita, ... RMD open 5 (2), e001064, 2019 | 70 | 2019 |
| Long-term follow-up in primary Sjögren’s syndrome reveals differences in clinical presentation between female and male patients JI Ramírez Sepúlveda, M Kvarnström, P Eriksson, T Mandl, KB Norheim, ... Biology of sex differences 8, 1-9, 2017 | 69 | 2017 |
| Takayasu arteritis in southern Sweden AJ Mohammad, T Mandl The Journal of rheumatology 42 (5), 853-858, 2015 | 66 | 2015 |
Xavier MarietteUniversité Paris-Saclay, Assistance Publique Hôpitaux de Paris, INSERMVerified email at aphp.fr
